[go: up one dir, main page]

DE60302676D1 - Mucoadhäsive, wärmeaktivierbare Zubereitung als Träger für Medikamente - Google Patents

Mucoadhäsive, wärmeaktivierbare Zubereitung als Träger für Medikamente

Info

Publication number
DE60302676D1
DE60302676D1 DE60302676T DE60302676T DE60302676D1 DE 60302676 D1 DE60302676 D1 DE 60302676D1 DE 60302676 T DE60302676 T DE 60302676T DE 60302676 T DE60302676 T DE 60302676T DE 60302676 D1 DE60302676 D1 DE 60302676D1
Authority
DE
Germany
Prior art keywords
medicaments
mucoadhesive
carrier
activatable
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60302676T
Other languages
English (en)
Other versions
DE60302676T2 (de
Inventor
Tsai Tsui-Min
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PHARMA POWER BIOTEC Co Ltd
Original Assignee
PHARMA POWER BIOTEC Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PHARMA POWER BIOTEC Co Ltd filed Critical PHARMA POWER BIOTEC Co Ltd
Publication of DE60302676D1 publication Critical patent/DE60302676D1/de
Application granted granted Critical
Publication of DE60302676T2 publication Critical patent/DE60302676T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/0019Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/00615-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0063Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015Drug-containing film-forming compositions, e.g. spray-on

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60302676T 2002-02-01 2003-01-22 Mucoadhäsive, wärmeaktivierbare Zubereitung als Träger für Medikamente Expired - Lifetime DE60302676T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNB021032564A CN1224424C (zh) 2002-02-01 2002-02-01 粘膜吸附性的热凝性医药载体组合物
CN02103256 2002-02-01

Publications (2)

Publication Number Publication Date
DE60302676D1 true DE60302676D1 (de) 2006-01-19
DE60302676T2 DE60302676T2 (de) 2006-09-07

Family

ID=4739817

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60302676T Expired - Lifetime DE60302676T2 (de) 2002-02-01 2003-01-22 Mucoadhäsive, wärmeaktivierbare Zubereitung als Träger für Medikamente

Country Status (5)

Country Link
EP (1) EP1332764B1 (de)
CN (1) CN1224424C (de)
AT (1) ATE312626T1 (de)
DE (1) DE60302676T2 (de)
DK (1) DK1332764T3 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2422804A1 (de) * 2004-06-17 2012-02-29 Amano Enzyme USA., Ltd. Formulierungen von Enzymen, Mikroorganismen und Antikörpern mit mucoadhäsiven Polymeren mit kontrollierter Freisetzung
US7592021B2 (en) 2004-10-02 2009-09-22 Sri International Bioadhesive delivery system for transmucosal delivery of beneficial agents
US20070082048A1 (en) * 2005-06-08 2007-04-12 Ronald Warner Sleep aid formulations
RU2013147883A (ru) * 2011-04-01 2015-05-10 Юниверсити Оф Флорида Рисеч Фаундэйшн, Инк. Термочувствительные, мукоадгезивные или кожно-адгезивные и усиливающие проникновение композиции для местной доставки терапевтических средств
CN103405769A (zh) 2013-03-07 2013-11-27 北京亿仁赛博医疗科技研发中心有限公司 光敏剂在制备治疗疾病的病毒灭活药物中的应用
CN103432581A (zh) 2013-03-22 2013-12-11 北京海思威科技有限公司 速立氧注射剂在制备治疗疾病的病毒灭活中的应用
AR100864A1 (es) * 2014-06-09 2016-11-09 Klox Tech Inc Composiciones biofotónicas termoendurecibles y sus usos
ITUB20152862A1 (it) * 2015-08-05 2017-02-05 Teres Srl Veicolo per terapia fotodinamica topica con acido delta-aminolevulinico in ambito dermatologico e metodo di preparazione del veicolo stesso.
CN105534739A (zh) * 2015-12-31 2016-05-04 杭州惠康医疗器械有限公司 一种复合凝胶

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0551626A1 (de) * 1991-12-19 1993-07-21 LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. Thermoreversible Gel als pharmazeutische Grundmasse für eine galenische Form

Also Published As

Publication number Publication date
CN1435261A (zh) 2003-08-13
ATE312626T1 (de) 2005-12-15
DK1332764T3 (da) 2006-05-01
CN1224424C (zh) 2005-10-26
EP1332764B1 (de) 2005-12-14
DE60302676T2 (de) 2006-09-07
EP1332764A1 (de) 2003-08-06

Similar Documents

Publication Publication Date Title
PT896533E (pt) Pentafluorobenzenosulfonamidas e analogos
BR9914638A (pt) Composto, método para a preparação do mesmo, composição farmacêutica, uso de um composto, e, método para o tratamento de um distúrbio ou doença de um corpo de animal vivo
PT911331E (pt) Compostos de dibenzoxazepina substituidos composicoes farmaceuticas e metodos de utilizacao
TR200401029T4 (tr) Asilfenil-üre türevleri, imalat yöntemleri ve ilaç maddesi olarak kullanımları
BR0001254A (pt) Composição que compreende pelo menos um composto bicìclico aromático, utilização da composição e processo de solubilização de um composto bicìclico aromático
CY1107899T1 (el) 6.αλφα., 9.αλφα. - διφθορο-17.αλφα.-(2-φουρανυλοανθρακοξυλικο) οξυ-11.βητα.-υδροξυ-16.αλφα.-μεθυλο-3-οξο-ανδροστα-1,4-διενιο-17-ανθρακοθειϊκο οξυ s-φθορομεθυλο εστερας ως αντιφλεγμονωδης παραγοντας
DE69936848D1 (de) Verwendung von d-serine oder d-alanine zur behandlung von schizophrenie
DK1137762T3 (da) Behandling af Pompes sygdom
BR0116370A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente.
DE60126980D1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
FI93831B (fi) Tetratsolit, jotka ovat verenpainetta alentavien yhdisteiden välituotteita
BR0206495A (pt) Tratamento de distúrbios de cns empregando antagonistas de oxidase de d-aminoácido e oxidase de d-aspartato
BRPI0410316A (pt) composto, composição farmacêutica, uso dos compostos, e, método de tratamento de distúrbios mediados por vr1 e para o tratamento de distúrbios de dores
WO2003104425A3 (en) NEW STABLE ANTI-CD22 ANTIBODIES
DE60302676D1 (de) Mucoadhäsive, wärmeaktivierbare Zubereitung als Träger für Medikamente
EE200400031A (et) Biokeemiliste ühendite kompositsioon, selle kasutamine maatriks-metalloproteinaaside pärssimiseks ning seda sisaldav ravimpreparaat
DE69707372D1 (de) Verwendung eines Phosphorsäurediesters zur Herstellung eines Arzneimittels zur Behandlung von Akne
IT1307786B1 (it) Analoghi di ceramidi, processo per la loro preparazione e loro usocome antitumorali.
SE9903611D0 (sv) Novel compounds III
DK0853476T5 (da) Nimesulidholdigt farmaceutisk præparat til topisk anvendelse
DE59101267D1 (de) N-Alkyl-N-(meth)acryloyloxyalkylcarboxamide aromatischer Carbonsäuren und aromatischer Carbonsäureanhydride sowie Adhäsive enthaltend diese Verbindungen.
ATE399526T1 (de) Pharmazeutische und kosmetische formulierungen zur behandlung der nägel
BR0007183A (pt) Isonipectoamidas para o tratamento de distúrbios mediados por integrina
DK0876144T3 (da) Terapeutiske anti-astmamidler indeholdende organiske selenforbindelser
DE69400352D1 (de) 3- oder 4-Glykosyloxybenzopyranderivat und dieses enthaltende antiallergisches Mittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: VIERING, JENTSCHURA & PARTNER, 81675 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: VIERING, JENTSCHURA & PARTNER, 01097 DRESDEN